Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

US Patent 8101754 · Granted Jan 24, 2012

Estimated economic value: $22,925,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Organic reactions carried out in aqueous solution in the presence of a hydroxyal2022
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2020
Fused heterocyclic compounds as S1P modulators2020
Inhibitor compounds of phosphodiesterase type 10A2019
Quinoline compounds suitable for treating disorders that respond to the modulati2018
Quinoline compounds suitable for treating disorders that respond to the modulati2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018